Illumina Stock Z Score

ILMN Stock

USD 144.36 1.41 0.99%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Illumina Piotroski F Score and Illumina Valuation analysis.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

At this time, Illumina's Capital Surpluse is very stable compared to the past year. As of the 28th of November 2024, Additional Paid In Capital is likely to grow to about 3.4 B, while Capital Lease Obligations is likely to drop about 559.5 M. At this time, Illumina's Total Operating Expenses is very stable compared to the past year. As of the 28th of November 2024, Income Tax Expense is likely to grow to about 75 M, while Interest Expense is likely to drop about 60.3 M.

Illumina Company Z Score Analysis

Illumina's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Illumina Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Illumina is extremely important. It helps to project a fair market value of Illumina Stock properly, considering its historical fundamentals such as Z Score. Since Illumina's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Illumina's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Illumina's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Net Tangible Assets	Capital Surpluse	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Cash And Equivalents
Total Assets		0.98	0.71	0.51	0.98	0.91	-0.21	0.95	0.52	0.35	0.86	0.5	0.93	0.73	0.94	0.88	-0.91	0.54	0.86	0.78	0.79	0.81	0.95	-0.4	-0.37	-0.15
Total Stockholder Equity	0.98		0.64	0.6	0.95	0.85	-0.2	0.88	0.49	0.26	0.81	0.45	0.87	0.71	0.93	0.92	-0.88	0.45	0.81	0.76	0.77	0.77	0.96	-0.33	-0.31	-0.28
Net Debt	0.71	0.64		-0.11	0.72	0.65	-0.41	0.78	0.05	0.41	0.87	0.3	0.69	0.56	0.61	0.7	-0.49	0.26	0.82	0.68	0.33	0.8	0.71	-0.8	-0.49	0.09
Retained Earnings	0.51	0.6	-0.11		0.48	0.36	0.46	0.32	0.73	0.23	0.03	0.38	0.39	0.35	0.58	0.44	-0.62	0.17	0.05	0.17	0.62	0.12	0.48	0.44	0.33	-0.57
Accounts Payable	0.98	0.95	0.72	0.48		0.93	-0.18	0.96	0.54	0.4	0.83	0.55	0.96	0.75	0.95	0.83	-0.92	0.55	0.84	0.77	0.79	0.77	0.89	-0.43	-0.38	-0.09
Net Receivables	0.91	0.85	0.65	0.36	0.93		-0.11	0.95	0.59	0.33	0.78	0.6	0.99	0.69	0.91	0.65	-0.91	0.74	0.85	0.72	0.8	0.79	0.75	-0.31	-0.57	0.15
Short Term Investments	-0.21	-0.2	-0.41	0.46	-0.18	-0.11		-0.21	0.64	0.34	-0.62	0.31	-0.12	-0.16	-0.05	-0.44	-0.06	0.08	-0.53	-0.53	0.16	-0.26	-0.34	0.74	0.4	-0.09
Total Liab	0.95	0.88	0.78	0.32	0.96	0.95	-0.21		0.54	0.5	0.86	0.55	0.96	0.72	0.89	0.74	-0.9	0.66	0.89	0.76	0.77	0.83	0.84	-0.49	-0.46	0.11
Total Current Assets	0.52	0.49	0.05	0.73	0.54	0.59	0.64	0.54		0.59	0.07	0.7	0.58	0.46	0.59	0.17	-0.75	0.58	0.16	0.17	0.77	0.28	0.32	0.34	0.15	0.03
Short Term Debt	0.35	0.26	0.41	0.23	0.4	0.33	0.34	0.5	0.59		0.2	0.28	0.38	0.21	0.31	0.1	-0.43	0.36	0.18	0.08	0.42	0.36	0.29	-0.18	0.18	0.19
Intangible Assets	0.86	0.81	0.87	0.03	0.83	0.78	-0.62	0.86	0.07	0.2		0.23	0.8	0.6	0.73	0.84	-0.65	0.43	0.97	0.83	0.51	0.86	0.87	-0.75	-0.59	0.06
Common Stock	0.5	0.45	0.3	0.38	0.55	0.6	0.31	0.55	0.7	0.28	0.23		0.57	0.8	0.51	0.29	-0.62	0.28	0.26	0.41	0.52	0.21	0.27	-0.05	0.04	0.11
Current Deferred Revenue	0.93	0.87	0.69	0.39	0.96	0.99	-0.12	0.96	0.58	0.38	0.8	0.57		0.68	0.94	0.69	-0.94	0.73	0.87	0.72	0.82	0.79	0.78	-0.36	-0.54	0.12
Long Term Debt	0.73	0.71	0.56	0.35	0.75	0.69	-0.16	0.72	0.46	0.21	0.6	0.8	0.68		0.67	0.69	-0.65	0.18	0.55	0.83	0.57	0.41	0.62	-0.42	-0.02	-0.06
Property Plant Equipment	0.94	0.93	0.61	0.58	0.95	0.91	-0.05	0.89	0.59	0.31	0.73	0.51	0.94	0.67		0.78	-0.91	0.59	0.79	0.73	0.86	0.75	0.84	-0.26	-0.42	-0.13
Good Will	0.88	0.92	0.7	0.44	0.83	0.65	-0.44	0.74	0.17	0.1	0.84	0.29	0.69	0.69	0.78		-0.65	0.12	0.76	0.8	0.51	0.68	0.95	-0.52	-0.24	-0.43
Treasury Stock	-0.91	-0.88	-0.49	-0.62	-0.92	-0.91	-0.06	-0.9	-0.75	-0.43	-0.65	-0.62	-0.94	-0.65	-0.91	-0.65		-0.73	-0.72	-0.6	-0.89	-0.67	-0.77	0.14	0.31	-0.01
Net Tangible Assets	0.54	0.45	0.26	0.17	0.55	0.74	0.08	0.66	0.58	0.36	0.43	0.28	0.73	0.18	0.59	0.12	-0.73		0.6	0.29	0.73	0.61	0.36	0.0	-0.57	0.53
Capital Surpluse	0.86	0.81	0.82	0.05	0.84	0.85	-0.53	0.89	0.16	0.18	0.97	0.26	0.87	0.55	0.79	0.76	-0.72	0.6		0.79	0.6	0.9	0.83	-0.64	-0.71	0.17
Long Term Debt Total	0.78	0.76	0.68	0.17	0.77	0.72	-0.53	0.76	0.17	0.08	0.83	0.41	0.72	0.83	0.73	0.8	-0.6	0.29	0.79		0.6	0.63	0.75	-0.64	-0.31	0.05
Long Term Investments	0.79	0.77	0.33	0.62	0.79	0.8	0.16	0.77	0.77	0.42	0.51	0.52	0.82	0.57	0.86	0.51	-0.89	0.73	0.6	0.6		0.62	0.65	-0.07	-0.2	0.1
Short Long Term Debt	0.81	0.77	0.8	0.12	0.77	0.79	-0.26	0.83	0.28	0.36	0.86	0.21	0.79	0.41	0.75	0.68	-0.67	0.61	0.9	0.63	0.62		0.82	-0.49	-0.62	0.13
Net Invested Capital	0.95	0.96	0.71	0.48	0.89	0.75	-0.34	0.84	0.32	0.29	0.87	0.27	0.78	0.62	0.84	0.95	-0.77	0.36	0.83	0.75	0.65	0.82		-0.45	-0.29	-0.31
Net Working Capital	-0.4	-0.33	-0.8	0.44	-0.43	-0.31	0.74	-0.49	0.34	-0.18	-0.75	-0.05	-0.36	-0.42	-0.26	-0.52	0.14	0.0	-0.64	-0.64	-0.07	-0.49	-0.45		0.34	-0.25
Capital Stock	-0.37	-0.31	-0.49	0.33	-0.38	-0.57	0.4	-0.46	0.15	0.18	-0.59	0.04	-0.54	-0.02	-0.42	-0.24	0.31	-0.57	-0.71	-0.31	-0.2	-0.62	-0.29	0.34		-0.33
Cash And Equivalents	-0.15	-0.28	0.09	-0.57	-0.09	0.15	-0.09	0.11	0.03	0.19	0.06	0.11	0.12	-0.06	-0.13	-0.43	-0.01	0.53	0.17	0.05	0.1	0.13	-0.31	-0.25	-0.33

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Illumina

According to the company's disclosures, Illumina has a Z Score of 0.0. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Illumina ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.

Environmental

Governance

Social

Illumina Institutional Holders

Institutional Holdings refers to the ownership stake in Illumina that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Illumina's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Illumina's value.

		Shares
Primecap Management Company	2024-09-30	2.5 M
Alliancebernstein L.p.	2024-06-30	2.5 M
Corvex Management Lp	2024-09-30	2.3 M
Norges Bank	2024-06-30	2.1 M
Nuveen Asset Management, Llc	2024-06-30	1.9 M
Bank Of America Corp	2024-06-30	1.6 M
Legal & General Group Plc	2024-06-30	1.6 M
Hhg Plc	2024-06-30	1.5 M
Millennium Management Llc	2024-06-30	1.5 M
Blackrock Inc	2024-06-30	18.1 M
Vanguard Group Inc	2024-09-30	15.9 M

Illumina Fundamentals

	Return On Equity	-0.4
	Return On Asset	0.0262
	Profit Margin	(0.36) %
	Operating Margin	0.24 %
	Current Valuation	24.54 B
	Shares Outstanding	158.6 M
	Shares Owned By Insiders	0.27 %
	Shares Owned By Institutions	95.17 %
	Number Of Shares Shorted	6.72 M
	Price To Earning	49.12 X
	Price To Book	10.73 X
	Price To Sales	5.16 X
	Revenue	4.5 B
	Gross Profit	3.15 B
	EBITDA	(1.07 B)
	Net Income	(1.16 B)
	Cash And Equivalents	2.01 B
	Cash Per Share	6.62 X
	Total Debt	2.26 B
	Debt To Equity	0.38 %
	Current Ratio	0.93 X
	Book Value Per Share	13.45 X
	Cash Flow From Operations	478 M
	Short Ratio	3.97 X
	Earnings Per Share	(9.97) X
	Price To Earnings To Growth	0.62 X
	Target Price	164.6
	Number Of Employees	10.59 K
	Beta	1.13
	Market Capitalization	22.67 B
	Total Asset	10.11 B
	Retained Earnings	(19 M)
	Working Capital	1.04 B
	Current Asset	2.1 B
	Current Liabilities	610.49 M
	Net Asset	10.11 B

About Illumina Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

0.74

DRUG

Bright Minds Biosciences

Pair Corr

Moving against Illumina Stock

0.77	FDMT	4D Molecular Therapeutics	Pair Corr
0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.63	ICU	LMF Acquisition Oppo	Pair Corr
0.5	VALN	Valneva SE ADR	Pair Corr
0.48	VRAX	Virax Biolabs Group	Pair Corr

The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.

The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:

How To Invest In Illumina

Details

Is Illumina Stock a good investment?

Details

What is Illumina's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Illumina Piotroski F Score and Illumina Valuation analysis.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

(9.97)

Revenue Per Share

27.654

Quarterly Revenue Growth

(0.04)

Return On Assets

0.0262

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Illumina Stock Z Score

Illumina Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Illumina Z Score Driver Correlations

Illumina ESG Sustainability

Illumina Institutional Holders

Illumina Fundamentals

About Illumina Fundamental Analysis

Pair Trading with Illumina

Moving together with Illumina Stock

Moving against Illumina Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY